Red Cell Distribution Width Across the Glycemic Spectrum: Association and Exploratory Diagnostic Performance in Prediabetes and Type 2 Diabetes
Endocrinology, Diabetes & Metabolism · 2026-11 · 9 (6)
DOI: 10.1002/edm2.70399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 18.11.2026. Verfasst von Saad Al‐fawaeir und 3 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Red cell distribution width (RDW) is routinely available, but its relationship with glycemic status requires cautious evaluation.
Methods
This cross‐sectional study included 300 Jordanian adults recruited using quotas of 100 per category. Normoglycemia and prediabetes were HbA1c‐defined; T2DM was clinically established. Analyses included pooled and within‐group Spearman correlations, HC3 regression, haematological sensitivity analyses, and internal ROC validation.
Results
Median RDW‐CV was 13.20%, 14.05%, and 14.90% in normoglycemia, prediabetes, and T2DM, respectively ( p < 0.001). Pooled rho was 0.973; within‐group rho ranged from 0.813 to 0.858. The category model adjusted for age, sex, and BMI had R 2 = 0.802 and adjusted R 2 = 0.799. After adding haemoglobin and MCV, category differences were 0.920 and 1.928 percentage points (both p < 0.001). Forty‐two records fell below unadjusted adult sex‐specific haemoglobin thresholds; associations remained in the separate 258‐participant sensitivity subset. The apparent AUCs for prediabetes were 0.9489 (95% bootstrap CI 0.918–0.972) and 1.000 for T2DM versus normoglycemia. For prediabetes, repeated five‐fold cross‐validation resulted in a mean sensitivity of 84.45% and specificity of 89.00%.
Conclusion
These selected‐sample associations do not support independence from unmeasured clinical confounding, screening utility, causality, or prediction of future diabetes. The discrepancy between anaemia and eligibility must be resolved. Internal validation cannot correct for the selected clinical spectrum or shared erythrocyte influences on RDW and HbA1c. Independent measurement verification and external validation with suitable glycemic reference standards are required.
Zitieren
APA
Al‐fawaeir, S., Alwardat, S., Abudayah, A., & Hammouri, H. (2026). Red Cell Distribution Width Across the Glycemic Spectrum: Association and Exploratory Diagnostic Performance in Prediabetes and Type 2 Diabetes. Endocrinology, Diabetes & Metabolism, 9(6). https://doi.org/10.1002/edm2.70399
Vancouver
Al‐fawaeir S, Alwardat S, Abudayah A, Hammouri H. Red Cell Distribution Width Across the Glycemic Spectrum: Association and Exploratory Diagnostic Performance in Prediabetes and Type 2 Diabetes. Endocrinology, Diabetes & Metabolism. 2026;9(6). doi:10.1002/edm2.70399
BibTeX
@article{Alfawaeir2026,
author = {Al‐fawaeir, Saad and Alwardat, Sofian and Abudayah, Alaa and Hammouri, Hanan},
title = {Red Cell Distribution Width Across the Glycemic Spectrum: Association and Exploratory Diagnostic Performance in Prediabetes and Type 2 Diabetes},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {6},
doi = {10.1002/edm2.70399}
}
EUVIMED